WARF Venture Startup Portfolio Stats
WARF holds equity in more than 30 of these companies, and more than 50 are located in Wisconsin. Some of these companies have achieved IPO status as publicly traded companies and have been acquired by large, well-established companies, such as Roche, Johnson & Johnson and Hologic.
Interested in learning more about one of these companies? Contact [email protected]
Artificial intelligence to evaluate treatment response in complex diseases.
Device to improve atrial arrhythmia diagnosis.
The world's lightest, most powerful non-rare earth electric motors and non-contact power transfer devices
Innovative cancer drug development.
Utilizes the power of quantum physics to build computer hardware and software with potential capabilities beyond traditional computing.
Conversational intelligence platform.
Innovative surgical navigation tool for tumor excision.
Developing sitruin drugs
Screening and determination of the aggressiveness of prostate cancer.
Integrated software solutions for radiomics enabled clinical management and clinical trials.
Gene therapy for pediatric patients with a retinal blinding disease.
Breath-based biomarkers that provide an early, pre-symptomatic warning of a developing severe infection
Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes through upright positioning
(Live Undiscovered Music), a music streaming platform dedicated to helping listeners discover and support new artists
Personalized cancer treatments to patients.
DNA vaccines intended to treat prostate cancer at crucial stages in the disease
Vaccines and diagnostics to fight animal and human infectious diseases
Globally accessible, non-invasive and precise diagnostic test for ovarian cancer.
Organosilicon compounds for energy storage devices, especially electrolytes for lithium-ion batteries
Composable compute platform which accelerates the abilities of artificial intelligence and machine-learning
Metabolomic technologies to understand cell biology in both health and disease
Improved drug delivery using collagen mimetic peptides
Seeking to discover and develop a bispecific antibody therapuetic for the treatment of neuroblastoma
Reliable, rugged and efficient laser and electro-optical systems for defense and security applications
Fully functioning human cells in industrial quantities IPO preceded acquisition Acquired by Fujifilm in 2015
Gala Design, Inc
Pharmaceuticals and biotech company focused on pharmaceutical preparations business.
Fast, minimally invasive and highly effective soft tissue ablation system Acquired by Ethicon in 2016
DNA microarrays, consumables and instruments Acquired by Roche in 2007
Skin regeneration and repair products for therapeutic use Acquired by Mallinckrodt Pharmaceuticals in 2016
Online studying platform for high school and college students.
Molecular diagnostics for DNA and RNA analysis applications Acquired by Hologic in 2008
Skeletal reconstruction and bone regeneration technology
Precise cancer treatment system IPO preceded acquisition Acquired by Accuray in 2011
Platform that converts soluble biomass-derived sugars into gasoline, diesel and more Acquired by TESORO in 2016